Association between methylenetetrahydrofolate reductase gene rs1801131 A/C polymorphism and urinary tumors’ susceptibility
Open Access
- 27 April 2020
- journal article
- research article
- Published by Springer Nature in Hereditas
- Vol. 157 (1) , 1-15
Abstract
The methylenetetrahydrofolate reductase (MTHFR) rs1801131 A/C variant results in a decrease in MTHFR enzymatic activity, which may play an important role in folate metabolism and is also an important source of DNA methylation and DNA synthesis. Several case-control studies have been conducted to assess the association of MTHFR rs1801131 polymorphism with the risk of urinary cancers, yet with conflicting conclusions. To derive a more precise estimation of above relationship, the association between the MTHFR rs1801131 A/C polymorphism and the risk of urinary cancer was performed. A total of 28 case-control studies was identified. The odds ratios (OR) with 95% confidence intervals (CI) was calculated to assess. On one hand, we found that the MTHFR rs1801131 A/C polymorphism was associated with increased whole urinary cancers’ risk (for example CA vs. AA: OR = 1.12. 95%CI = 1.01–1.24). On the other hand, we found that the MTHFR rs1801131 A/C polymorphism might increase bladder cancer risk both in Asian (C-allele vs. A-allele: OR = 1.35. 95%CI = 1.15–1.60) and African populations (CA vs. AA: OR = 1.63. 95%CI = 1.17–2.25). Our current analysis suggested that MTHFR rs1801131 A/C is associated with urinary cancers, especially bladder cancer.Keywords
This publication has 56 references indexed in Scilit:
- Dietary Intake of Folate, B-Vitamins and Methionine and Breast Cancer Risk among Hispanic and Non-Hispanic White WomenPLOS ONE, 2013
- Genetic variation in Glutathione S-Transferase Omega-1, Arsenic Methyltransferase and Methylene-tetrahydrofolate Reductase, arsenic exposure and bladder cancer: a case–control studyEnvironmental Health, 2012
- No Association of Single Nucleotide Polymorphisms in One-Carbon Metabolism Genes with Prostate Cancer RiskCancer Epidemiology, Biomarkers & Prevention, 2008
- Polymorphisms of methylenetetrahydrofolate reductase and methionine synthase genes and bladder cancer risk: a case–control study with meta-analysisClinical and Experimental Medicine, 2008
- Association studies for finding cancer-susceptibility genetic variantsNature Reviews Cancer, 2004
- Investigation of genetic polymorphisms and smoking in a bladder cancer case–control study in ArgentinaCancer Letters, 2004
- Polymorphisms of folate metabolic genes and susceptibility to bladder cancer: a case-control studyCarcinogenesis, 2004
- Measuring inconsistency in meta-analysesBMJ, 2003
- A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductaseNature Genetics, 1995
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986